Valuation: Abbott Laboratories

Market Cap 178B 162B 150B 136B 255B 16,519B 269B 1,822B 724B 9,023B 669B 655B 28,316B P/E 2026 *
34.1x
P/E 2027 * 24.8x
Enterprise Value 202B 184B 169B 154B 289B 18,700B 304B 2,063B 820B 10,214B 758B 742B 32,055B EV / Sales 2026 *
4.04x
EV / Sales 2027 * 3.71x
Free-Float
86.17%
Yield 2026 *
2.52%
Yield 2027 * 2.68%
1 day-0.84%
1 week-5.09%
Current month-3.01%
1 month+2.48%
3 months-11.69%
6 months+17.35%
Current year-17.79%
1 week 102.8
Extreme 102.8
110.44
1 month 101.54
Extreme 101.5367
117.07
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
129.85
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 30/03/2020
Director of Finance/CFO 53 31/08/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 08/12/2011
Director/Board Member 67 08/12/2011
Director/Board Member 71 15/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
30/09/26 Free

Director

333 0.0000%
30/09/26 Free

Director

318 0.0000%
30/09/26 Free

Director

381 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.84%-5.09%-19.60%+1.07% 178B
-0.67%-2.84%-1.25%+27.12% 122B
-0.98%+0.12%-15.82%+5.56% 118B
-1.24%-4.25%-42.94%-1.34% 88.1B
-0.63%-5.55%-7.27%+70.54% 64.71B
+0.05%-2.41%+10.41%-9.90% 57.96B
-1.95%-3.98%-6.85%+41.55% 53.28B
-2.91%-4.35%-0.97%+38.45% 47.8B
-1.64%+1.50%+1.30%-2.04% 35.65B
-2.11%-6.16% - - 32.55B
Average -1.29%-2.98%-9.22%+19.00% 80B
Weighted average by Cap. -1.08%-3.10%-12.44%+15.68%

Financials

2026 *2027 *
Net sales 49.95B 45.49B 41.92B 38.13B 71.53B 4,625B 75.18B 510B 203B 2,526B 187B 183B 7,928B 53.5B 48.73B 44.9B 40.84B 76.62B 4,954B 80.53B 546B 217B 2,706B 201B 196B 8,492B
Net income 5.64B 5.14B 4.74B 4.31B 8.08B 523B 8.49B 57.64B 22.91B 285B 21.17B 20.73B 896B 7.66B 6.98B 6.43B 5.85B 10.97B 709B 11.53B 78.23B 31.09B 387B 28.73B 28.13B 1,216B
Net Debt 23.55B 21.45B 19.77B 17.98B 33.73B 2,181B 35.45B 241B 95.63B 1,191B 88.38B 86.51B 3,739B 20.14B 18.34B 16.9B 15.37B 28.84B 1,865B 30.31B 206B 81.76B 1,019B 75.56B 73.97B 3,197B
Projected Income Statement - Annual - Abbott Laboratories
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
20/11/26 US$103.00 -0.84% 7,300,838
19/11/26 US$103.87 -0.58% 7,507,275
18/11/26 US$104.48 -0.22% 7,605,008
17/11/26 US$104.71 -2.55% 5,924,133
16/11/26 US$107.45 -0.99% 8,809,066
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Abbott Laboratories
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
103.00USD
Average target price
119.60USD
Spread / Average Target
+16.12%